Scientists have reportedly administered the first human patient with a revolutionary cancer-killing virus, known as Vaxinia, which has delivered successful results during animal testing.
Now, the true test of the virus’ efficacy will begin with the new clinical trial.
It is hoped that the body’s immune response will be amplified against cancer with the virus, which has been specifically engineered to kill cancer cells.
In the last decade, such viruses had delivered very limited successes, however this time around, scientists developed this cancer-killing virus to harm cancer cells w